Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- المؤلفون: Rodon, J.; Rodriguez, E.; Maitland, M.L.; Tsai, F.Y.-C.; Socinski, M.A.; Berlin, J.D.; Thomas, J.S.; Al Baghdadi, T.; Wang, I.-M.; Guo, C.; Golmakani, M.; Clark, L.N.; Gazdoiu, M.; Li, M.; Tolcher, A.W.
- المصدر:
ESMO Open ; volume 9, issue 4, page 102961 ; ISSN 2059-7029
- الموضوع:
- نوع التسجيلة:
article in journal/newspaper
- اللغة:
English
- معلومة اضافية
- Contributors:
Pfizer
- بيانات النشر:
Elsevier BV
- الموضوع:
2024
- Collection:
ScienceDirect (Elsevier - Open Access Articles via Crossref)
- الرقم المعرف:
10.1016/j.esmoop.2024.102961
- Rights:
https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license ; http://creativecommons.org/licenses/by-nc-nd/4.0/
- الرقم المعرف:
edsbas.75AB8EED
No Comments.